Hims & Hers Health (HIMS)
NYSE:HIMS
Want to see HIMS full AI Analyst Report?
HIMS Analyst Ratings
Moderate Buy
5 Buy
10 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
HIMS Stock 12 Month Forecast
Average Price Target
$28.27
▼(-1.90% Downside)
| Highest Price Target$35.00 | Average Price Target$28.27 | Lowest Price Target$21.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
J.P. Morgan
$35
Buy
21.44%
Upside
Initiated
04/24/26
Bank of America Securities
$30→$32
Hold
11.03%
Upside
Reiterated
04/23/26
Morgan Stanley
$21
Hold
-27.13%
Downside
Reiterated
04/22/26
Citi
$24
Hold
-16.72%
Downside
Reiterated
04/21/26
Leerink Partners
―
Hold
―
Reiterated
04/16/26
Truist Financial
―
Hold
―
Reiterated
04/13/26
TD Cowen
$25→$23
Hold
-20.19%
Downside
Reiterated
03/27/26
Canaccord Genuity
$30
Buy
4.09%
Upside
Reiterated
03/26/26
Barclays
$25→$29
Buy
0.62%
Upside
Assigned
03/11/26
Deutsche Bank
$25→$28
Hold
-2.85%
Downside
Reiterated
03/10/26
Needham
$30
Buy
4.09%
Upside
Upgraded
03/09/26
BTIG
―
Hold
―
Reiterated
03/05/26
Evercore ISI
$33→$24
Hold
-16.72%
Downside
Reiterated
02/24/26
KeyBanc
―
Hold
―
Reiterated
02/24/26
Analyst Type
Any
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
J.P. Morgan
$35
Buy
21.44%
Upside
Initiated
04/24/26
Bank of America Securities
$30→$32
Hold
11.03%
Upside
Reiterated
04/23/26
Morgan Stanley
$21
Hold
-27.13%
Downside
Reiterated
04/22/26
Citi
$24
Hold
-16.72%
Downside
Reiterated
04/21/26
Leerink Partners
―
Hold
―
Reiterated
04/16/26
Truist Financial
―
Hold
―
Reiterated
04/13/26
TD Cowen
$25→$23
Hold
-20.19%
Downside
Reiterated
03/27/26
Canaccord Genuity
$30
Buy
4.09%
Upside
Reiterated
03/26/26
Barclays
$25→$29
Buy
0.62%
Upside
Assigned
03/11/26
Deutsche Bank
$25→$28
Hold
-2.85%
Downside
Reiterated
03/10/26
Needham
$30
Buy
4.09%
Upside
Upgraded
03/09/26
BTIG
―
Hold
―
Reiterated
03/05/26
Evercore ISI
$33→$24
Hold
-16.72%
Downside
Reiterated
02/24/26
KeyBanc
―
Hold
―
Reiterated
02/24/26
Best Analysts Covering Hims & Hers Health
3 Months
xxx
Success Rate
9/12 ratings generated profit
Average Return
+31.94%
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 75.00% of your transactions generating a profit, with an average return of +31.94% per trade.
1 Year
Success Rate
8/9 ratings generated profit
Average Return
+43.99%
Copying Glen Santangelo's trades and holding each position for 1 Year would result in 88.89% of your transactions generating a profit, with an average return of +43.99% per trade.
2 Years
xxx
Success Rate
8/9 ratings generated profit
Average Return
+45.26%
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 88.89% of your transactions generating a profit, with an average return of +45.26% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
HIMS Analyst Recommendation Trends
Rating
Dec 25
Jan 26
Feb 26
Mar 26
Apr 26
Strong Buy
1
1
6
7
7
Buy
1
1
1
4
5
Hold
13
12
20
31
36
Sell
13
13
12
9
6
Strong Sell
2
0
0
0
0
total
30
27
39
51
54
Each month's total comprises the sum of three months' worth of ratings.
HIMS Financial Forecast
HIMS Stock Forecast FAQ
What is HIMS’s average 12-month price target, according to analysts?
Based on analyst ratings, Hims & Hers Health’s 12-month average price target is 28.27.
What is HIMS’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for HIMS, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is HIMS a Buy, Sell or Hold?
Hims & Hers Health has a consensus rating of Moderate Buy which is based on 5 buy ratings, 10 hold ratings and 0 sell ratings.
What is Hims & Hers Health’s price target?
The average price target for Hims & Hers Health is 28.27. This is based on 15 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $35.00 ,the lowest forecast is $21.00. The average price target represents -1.90% Decrease from the current price of $28.82.
The highest analyst price target is $35.00 ,the lowest forecast is $21.00. The average price target represents -1.90% Decrease from the current price of $28.82.
What do analysts say about Hims & Hers Health?
Hims & Hers Health’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 15 Wall Streets Analysts.
How can I buy shares of HIMS?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.